Venetoclax-containing Therapy Combined With Microtransplant for Intermediate-risk and Higher MDS
Venetoclax-containing Therapy Combined With Microtransplant for Intermediate-risk and Higher MDS
Recruiting · NCT07238686 · Registry updated 2026-10-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Venetoclax-containing Therapy Combined With Microtransplant for Intermediate-risk and Higher MDS | Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder, myelodysplastic syndrome | Recruiting | Phase 2 | 2026-10-09 | NCT07238686 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing 302 Hospital | 32 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Department of Hematology, the Fifth Medical Center of Chinese PLA General Hospital | Beijing | China | 3 |